The 80th United Nations General Assembly (UNGA) marked a historical moment for the Israel-Palestine conflict. On September 22, France recognized the state of Palestine, following the UK and Portugal, ...

Israeli and US scientists have discovered how tiny gateways in human cells control what enters and leaves the cell's nucleus, solving a mystery that has puzzled researchers and could shed new light on ...

Galapagos changed course earlier this year, announcing it no longer wanted to focus on cell therapy and would seek buyers for this business. After shopping around the assets for months, Galapagos ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Shares in Galapagos NV dropped sharply after the Belgian biotech firm said it would wind down its cell-therapy operations, putting paid to plans to sell the business off after no viable offers were ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. After months of back-and-forth announcements, ...

Galapagos is scaling back its cell therapy business to focus on new business development opportunities and unmet needs. The decision follows a strategic review and unsuccessful attempts to find ...